AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹47 Cr | ₹29 Cr | ₹14 Cr | ₹4.25 Cr | ₹1.28 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹47 Cr |
Mar2022 | ₹29 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹4.25 Cr |
Mar2019 | ₹1.28 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹47 Cr | 60.86 | |
Mar2022 | ₹29 Cr | 108.75 | |
Mar2021 | ₹14 Cr | 230.95 | |
Mar2020 | ₹4.25 Cr | 232.73 | |
Mar2019 | ₹1.28 Cr | - |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹330.5 Cr | -7% | -20.2% | 99.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -7% |
-20.2% |
99.6% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses